Erratum: Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma (Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma (2015) 96(4) (597–611), (S0002929715001007), (10.1016/j.ajhg.2015.02.017));Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma

American Journal of Human Genetics

Volumn 96, Issue 4, 2015, Pages 597-611

  Zhang, Ling ^a   Zhou, Yong ^b   Cheng, Caixia ^a   Cui, Heyang ^a,b   Cheng, Le ^c   Kong, Pengzhou ^a   Wang, Jiaqian ^b   Li, Yin ^d   Chen, Wenliang ^b   Song, Bin ^a   Wang, Fang ^a   Jia, Zhiwu ^a   Li, Lin ^b   Li, Yaoping ^a,e   Yang, Bin ^a,e   Liu, Jing ^a   Shi, Ruyi ^a   Bi, Yanghui ^a   Zhang, Yanyan ^a   Wang, Juan ^a   Zhao, Zhenxiang ^a   Hu, Xiaoling ^a   Yang, Jie ^a   Li, Hongyi ^a   Gao, Zhibo ^b   Chen, Gang ^b   Huang, Xuanlin ^b   Yang, Xukui ^b   Wan, Shengqing ^b   Chen, Chao ^b   Li, Bin ^b   Tan, Yongkai ^b   Chen, Longyun ^b   He, Minghui ^b   Xie, Sha ^b   Li, Xiangchun ^b   Zhuang, Xuehan ^b   Wang, Mengyao ^b   Xia, Zhi ^b   Luo, Longhai ^b   Ma, Jie ^d   Dong, Bing ^d   Zhao, Jiuzhou ^d   Song, Yongmei ^f   Ou, Yunwei ^f   Li, Enming ^g   Xu, Liyan ^g   Wang, Jinfen ^e   Xi, Yanfeng ^e   Li, Guodong ^e   Xu, Enwei ^e   Liang, Jianfang ^a   Yang, Xiaofeng ^a   Guo, Jiansheng ^a   Chen, Xing ^h   Zhang, Yanbo ^a   Li, Qingshan ^a   Liu, Lixin ^a   Li, Yingrui ^b   Zhang, Xiuqing ^b   Yang, Huanming ^b   Lin, Dongxin ^f   Cheng, Xiaolong ^a   Guo, Yongjun ^d   Wang, Jun ^b   Zhan, Qimin ^f   Cui, Yongping ^a   more..

^a SHANXI MEDICAL UNIVERSITY   (China)

^b BGI SHENZHEN   (China)

^c BGI Yunnan BGI Shenzhen   (China)

^d HENAN CANCER HOSPITAL   (China)

^e SHANXI CANCER HOSPITAL   (China)

^f CANCER HOSPITAL   (China)

^g SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^h SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AJUBA PROTEIN; APOBEC PROTEIN; BAP1 PROTEIN; CBX4 PROTEIN; CBX8 PROTEIN; CREBBP PROTEIN; GENOMIC DNA; PROTEIN; PROTEIN PATCHED 1; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; ZNF750 PROTEIN; AJUBA PROTEIN, HUMAN; APOLIPOPROTEIN B MRNA EDITING ENZYME; BAP1 PROTEIN, HUMAN; BMI1 PROTEIN; CBX4 PROTEIN, HUMAN; CBX8 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; CREBBP PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTIDINE DEAMINASE; LIM PROTEIN; PATCHED RECEPTORS; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; POLYCOMB GROUP PROTEIN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN THIOLESTERASE; ZNF750 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CHINESE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DEAMINATION; DNA COPY NUMBER ALTERATION; DNA DAMAGE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOGENESIS; EXOME; FEMALE; GENE DOSAGE; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN TISSUE; INDEL MUTATION; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOUSE; MUTATION RATE; NONHUMAN; NONSENSE MUTATION; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR XENOGRAFT; ANALYSIS OF VARIANCE; CHINA; COPY NUMBER VARIATION; DNA SEQUENCE; ESOPHAGUS TUMOR; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ERINACEIDAE;

ANALYSIS OF VARIANCE; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHINA; CREB-BINDING PROTEIN; CYTIDINE DEAMINASE; DNA COPY NUMBER VARIATIONS; ESOPHAGEAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LIM DOMAIN PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; POLYCOMB REPRESSIVE COMPLEX 1; POLYCOMB-GROUP PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; TETRAZOLIUM SALTS; THIAZOLES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE; UBIQUITIN-PROTEIN LIGASES;

EID: 84926142624     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2020.07.008     Document Type: Erratum

References (50)

1. A. Pennathur, M.K. Gibson, B.A. Jobe, and J.D. Luketich Oesophageal carcinoma Lancet 381 2013 400 412
2. L.S. Engel, W.H. Chow, T.L. Vaughan, M.D. Gammon, H.A. Risch, J.L. Stanford, J.B. Schoenberg, S.T. Mayne, R. Dubrow, and H. Rotterdam Population attributable risks of esophageal and gastric cancers J. Natl. Cancer Inst. 95 2003 1404 1413
3. P. Jia, W. Pao, and Z. Zhao Patterns and processes of somatic mutations in nine major cancers BMC Med. Genomics 7 2014 11
4. E.D. Pleasance, R.K. Cheetham, P.J. Stephens, D.J. McBride, S.J. Humphray, C.D. Greenman, I. Varela, M.L. Lin, G.R. Ordóñez, and G.R. Bignell A comprehensive catalogue of somatic mutations from a human cancer genome Nature 463 2010 191 196
5. E.D. Pleasance, P.J. Stephens, S. O'Meara, D.J. McBride, A. Meynert, D. Jones, M.L. Lin, D. Beare, K.W. Lau, and C. Greenman A small-cell lung cancer genome with complex signatures of tobacco exposure Nature 463 2010 184 190
6. Y. Song, L. Li, Y. Ou, Z. Gao, E. Li, X. Li, W. Zhang, J. Wang, L. Xu, and Y. Zhou Identification of genomic alterations in oesophageal squamous cell cancer Nature 509 2014 91 95
7. D.C. Lin, J.J. Hao, Y. Nagata, L. Xu, L. Shang, X. Meng, Y. Sato, Y. Okuno, A.M. Varela, and L.W. Ding Genomic and molecular characterization of esophageal squamous cell carcinoma Nat. Genet. 46 2014 467 473
8. F. Duan, W. Xie, L. Cui, P. Wang, C. Song, H. Qu, K. Wang, J. Zhang, and L. Dai Novel functional variants locus in PLCE1 and susceptibility to esophageal squamous cell carcinoma: based on published genome-wide association studies in a central Chinese population Cancer Epidemiol. 37 2013 647 652
9. Y. Liu, L. Cao, J. Chang, J. Lin, B. He, J. Rao, Z. Zhang, and X. Zhang XPF-673C>T polymorphism effect on the susceptibility to esophageal cancer in Chinese population PLoS ONE 9 2014 e94136
10. Y. Fang, F. Xiao, Z. An, and L. Hao Systematic review on the relationship between genetic polymorphisms of methylenetetrahydrofolate reductase and esophageal squamous cell carcinoma Asian Pac. J. Cancer Prev. 12 2011 1861 1866
11. D.Y. Chiang, G. Getz, D.B. Jaffe, M.J. O'Kelly, X. Zhao, S.L. Carter, C. Russ, C. Nusbaum, M. Meyerson, and E.S. Lander High-resolution mapping of copy-number alterations with massively parallel sequencing Nat. Methods 6 2009 99 103
12. P. Van Loo, S.H. Nordgard, O.C. Lingjærde, H.G. Russnes, I.H. Rye, W. Sun, V.J. Weigman, P. Marynen, A. Zetterberg, and B. Naume Allele-specific copy number analysis of tumors Proc. Natl. Acad. Sci. USA 107 2010 16910 16915
13. C. Takenaka, N. Nishishita, N. Takada, L.M. Jakt, and S. Kawamata Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53 Exp. Hematol. 38 2010 154 162
14. J. Liu, X. Cheng, Y. Zhang, S. Li, H. Cui, L. Zhang, R. Shi, Z. Zhao, C. He, and C. Wang Phosphorylation of Mps1 by BRAFV600E prevents Mps1 degradation and contributes to chromosome instability in melanoma Oncogene 32 2013 713 723
15. S. Lal, J. La Du, R.L. Tanguay, and J.A. Greenwood Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment J. Neurosci. Res. 90 2012 769 781
16. P. Vagnarelli, D.F. Hudson, S.A. Ribeiro, L. Trinkle-Mulcahy, J.M. Spence, F. Lai, C.J. Farr, A.I. Lamond, and W.C. Earnshaw Condensin and Repo-Man-PP1 co-operate in the regulation of chromosome architecture during mitosis Nat. Cell Biol. 8 2006 1133 1142
17. L. Zhang, R. Shi, C. He, C. Cheng, B. Song, H. Cui, Y. Zhang, Z. Zhao, Y. Bi, and X. Yang Oncogenic B-Raf(V600E) abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells Cancer Lett. 337 2013 125 132
18. L.D. Wood, D.W. Parsons, S. Jones, J. Lin, T. Sjöblom, R.J. Leary, D. Shen, S.M. Boca, T. Barber, and J. Ptak The genomic landscapes of human breast and colorectal cancers Science 318 2007 1108 1113
19. A.M. Dulak, P. Stojanov, S. Peng, M.S. Lawrence, C. Fox, C. Stewart, S. Bandla, Y. Imamura, S.E. Schumacher, and E. Shefler Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity Nat. Genet. 45 2013 478 486
20. L.B. Alexandrov, S. Nik-Zainal, D.C. Wedge, P.J. Campbell, and M.R. Stratton Deciphering signatures of mutational processes operative in human cancer Cell Rep. 3 2013 246 259
21. S. Nik-Zainal, L.B. Alexandrov, D.C. Wedge, P. Van Loo, C.D. Greenman, K. Raine, D. Jones, J. Hinton, J. Marshall, L.A. Stebbings Breast Cancer Working Group of the International Cancer Genome Consortium Mutational processes molding the genomes of 21 breast cancers Cell 149 2012 979 993
22. R.S. Harris, S.K. Petersen-Mahrt, and M.S. Neuberger RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators Mol. Cell 10 2002 1247 1253
23. V. Caval, R. Suspène, J.P. Vartanian, and S. Wain-Hobson Orthologous mammalian APOBEC3A cytidine deaminases hypermutate nuclear DNA Mol. Biol. Evol. 31 2014 330 340
24. Q. Yu, D. Chen, R. König, R. Mariani, D. Unutmaz, and N.R. Landau APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication J. Biol. Chem. 279 2004 53379 53386
25. S. Henderson, A. Chakravarthy, X. Su, C. Boshoff, and T.R. Fenton APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development Cell Rep. 7 2014 1833 1841
26. T.R. Waters, and P.F. Swann Thymine-DNA glycosylase and G to A transition mutations at CpG sites Mutat. Res. 462 2000 137 147
27. Y. Lin, Y. Totsuka, Y. He, S. Kikuchi, Y. Qiao, J. Ueda, W. Wei, M. Inoue, and H. Tanaka Epidemiology of esophageal cancer in Japan and China J. Epidemiol. 23 2013 233 242
28. A. Pandey, S.C. Tripathi, S. Mahata, K. Vishnoi, S. Shukla, S.P. Misra, V. Misra, S. Hedau, R. Mehrotra, M. Dwivedi, and A.C. Bharti Carcinogenic Helicobacter pylori in gastric pre-cancer and cancer lesions: association with tobacco-chewing World J. Gastroenterol. 20 2014 6860 6868
29. L.B. Alexandrov, S. Nik-Zainal, D.C. Wedge, S.A. Aparicio, S. Behjati, A.V. Biankin, G.R. Bignell, N. Bolli, A. Borg, A.L. Børresen-Dale Australian Pancreatic Cancer Genome Initiative ICGC Breast Cancer Consortium ICGC MMML-Seq Consortium ICGC PedBrain Signatures of mutational processes in human cancer Nature 500 2013 415 421
30. C. Wu, Z. Hu, Z. He, W. Jia, F. Wang, Y. Zhou, Z. Liu, Q. Zhan, Y. Liu, and D. Yu Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations Nat. Genet. 43 2011 679 684
31. M. Hoogstraat, M.S. de Pagter, G.A. Cirkel, M.J. van Roosmalen, T.T. Harkins, K. Duran, J. Kreeftmeijer, I. Renkens, P.O. Witteveen, and C.C. Lee Genomic and transcriptomic plasticity in treatment-naive ovarian cancer Genome Res. 24 2014 200 211
32. Y. Gen, K. Yasui, T. Nishikawa, and T. Yoshikawa SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway Cancer Sci. 104 2013 810 816
33. M.R. Stratton Exploring the genomes of cancer cells: progress and promise Science 331 2011 1553 1558
34. K. Klauke, V. Radulović, M. Broekhuis, E. Weersing, E. Zwart, S. Olthof, M. Ritsema, S. Bruggeman, X. Wu, and K. Helin Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation Nat. Cell Biol. 15 2013 353 362
35. G. Li, C. Warden, Z. Zou, J. Neman, J.S. Krueger, A. Jain, R. Jandial, and M. Chen Altered expression of polycomb group genes in glioblastoma multiforme PLoS ONE 8 2013 e80970
36. M.S. Lawrence, P. Stojanov, P. Polak, G.V. Kryukov, K. Cibulskis, A. Sivachenko, S.L. Carter, C. Stewart, C.H. Mermel, and S.A. Roberts Mutational heterogeneity in cancer and the search for new cancer-associated genes Nature 499 2013 214 218
37. Y.B. Gao, Z.L. Chen, J.G. Li, X.D. Hu, X.J. Shi, Z.M. Sun, F. Zhang, Z.R. Zhao, Z.T. Li, and Z.Y. Liu Genetic landscape of esophageal squamous cell carcinoma Nat. Genet. 46 2014 1097 1102
38. N. Stransky, A.M. Egloff, A.D. Tward, A.D. Kostic, K. Cibulskis, A. Sivachenko, G.V. Kryukov, M.S. Lawrence, C. Sougnez, and A. McKenna The mutational landscape of head and neck squamous cell carcinoma Science 333 2011 1157 1160
39. S. Banerji, K. Cibulskis, C. Rangel-Escareno, K.K. Brown, S.L. Carter, A.M. Frederick, M.S. Lawrence, A.Y. Sivachenko, C. Sougnez, and L. Zou Sequence analysis of mutations and translocations across breast cancer subtypes Nature 486 2012 405 409
40. S. Jiang, H. Katayama, J. Wang, S.A. Li, Y. Hong, L. Radvanyi, J.J. Li, and S. Sen Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells Horm. Cancer 1 2010 11 20
41. V. James, Y. Zhang, D.E. Foxler, C.H. de Moor, Y.W. Kong, T.M. Webb, T.J. Self, Y. Feng, D. Lagos, and C.Y. Chu LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing Proc. Natl. Acad. Sci. USA 107 2010 12499 12504
42. T. Iwaya, C. Maesawa, S. Ogasawara, and G. Tamura Tylosis esophageal cancer locus on chromosome 17q25.1 is commonly deleted in sporadic human esophageal cancer Gastroenterology 114 1998 1206 1210
43. G.L. Sen, L.D. Boxer, D.E. Webster, R.T. Bussat, K. Qu, B.J. Zarnegar, D. Johnston, Z. Siprashvili, and P.A. Khavari ZNF750 is a p63 target gene that induces KLF4 to drive terminal epidermal differentiation Dev. Cell 22 2012 669 677
44. L.G. Morris, A.M. Kaufman, Y. Gong, D. Ramaswami, L.A. Walsh, Ş. Turcan, S. Eng, K. Kannan, Y. Zou, and L. Peng Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation Nat. Genet. 45 2013 253 261
45. H. Tukachinsky, L.V. Lopez, and A. Salic A mechanism for vertebrate Hedgehog signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes J. Cell Biol. 191 2010 415 428
46. E. Kuhn, R.C. Wu, B. Guan, G. Wu, J. Zhang, Y. Wang, L. Song, X. Yuan, L. Wei, and R.B. Roden Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses J. Natl. Cancer Inst. 104 2012 1503 1513
47. M. Iwatsuki, K. Mimori, H. Ishii, T. Yokobori, Y. Takatsuno, T. Sato, H. Toh, I. Onoyama, K.I. Nakayama, H. Baba, and M. Mori Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance Int. J. Cancer 126 2010 1828 1837
48. M. Le Gallo, A.J. O'Hara, M.L. Rudd, M.E. Urick, N.F. Hansen, N.J. O'Neil, J.C. Price, S. Zhang, B.M. England, A.K. Godwin NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes Nat. Genet. 44 2012 1310 1315
49. M. Gerlinger, S. Horswell, J. Larkin, A.J. Rowan, M.P. Salm, I. Varela, R. Fisher, N. McGranahan, N. Matthews, and C.R. Santos Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing Nat. Genet. 46 2014 225 233
50. M.S. Lawrence, P. Stojanov, C.H. Mermel, J.T. Robinson, L.A. Garraway, T.R. Golub, M. Meyerson, S.B. Gabriel, E.S. Lander, and G. Getz Discovery and saturation analysis of cancer genes across 21 tumour types Nature 505 2014 495 501